These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 19192961)
1. Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy. Abounader R Expert Rev Anticancer Ther; 2009 Feb; 9(2):235-45. PubMed ID: 19192961 [TBL] [Abstract][Full Text] [Related]
2. Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases. Zhang W; Lv Y; Xue Y; Wu C; Yao K; Zhang C; Jin Q; Huang R; Li J; Sun Y; Su X; Jiang T; Fan X Oncotarget; 2016 Sep; 7(37):59098-59114. PubMed ID: 27385209 [TBL] [Abstract][Full Text] [Related]
3. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Stommel JM; Kimmelman AC; Ying H; Nabioullin R; Ponugoti AH; Wiedemeyer R; Stegh AH; Bradner JE; Ligon KL; Brennan C; Chin L; DePinho RA Science; 2007 Oct; 318(5848):287-90. PubMed ID: 17872411 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy for malignant glioma based on PTEN status. Gonzalez J; de Groot J Expert Rev Anticancer Ther; 2008 Nov; 8(11):1767-79. PubMed ID: 18983237 [TBL] [Abstract][Full Text] [Related]
5. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells. Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633 [TBL] [Abstract][Full Text] [Related]
6. PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy. Haddadi N; Lin Y; Travis G; Simpson AM; Nassif NT; McGowan EM Mol Cancer; 2018 Feb; 17(1):37. PubMed ID: 29455665 [TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits. Jiang X; Chen S; Asara JM; Balk SP J Biol Chem; 2010 May; 285(20):14980-14989. PubMed ID: 20231295 [TBL] [Abstract][Full Text] [Related]
8. Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas. Han S; Wang PF; Cai HQ; Wan JH; Li SW; Lin ZH; Yu CJ; Yan CX Aging (Albany NY); 2021 Jun; 13(11):15444-15458. PubMed ID: 34100771 [TBL] [Abstract][Full Text] [Related]
10. A role for C. elegans Eph RTK signaling in PTEN regulation. Brisbin S; Liu J; Boudreau J; Peng J; Evangelista M; Chin-Sang I Dev Cell; 2009 Oct; 17(4):459-69. PubMed ID: 19853560 [TBL] [Abstract][Full Text] [Related]
11. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma. Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515 [TBL] [Abstract][Full Text] [Related]
12. Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches. Kapoor GS; O'Rourke DM Cancer Biol Ther; 2003; 2(4):330-42. PubMed ID: 14508101 [TBL] [Abstract][Full Text] [Related]
13. Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy. Li Y; Guessous F; DiPierro C; Zhang Y; Mudrick T; Fuller L; Johnson E; Marcinkiewicz L; Engelhardt M; Kefas B; Schiff D; Kim J; Abounader R Mol Cancer Ther; 2009 Feb; 8(2):376-85. PubMed ID: 19190120 [TBL] [Abstract][Full Text] [Related]
14. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines. Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337 [TBL] [Abstract][Full Text] [Related]
15. RACK1 affects glioma cell growth and differentiation through the CNTN2-mediated RTK/Ras/MAPK pathway. Yan Y; Jiang Y Int J Mol Med; 2016 Jan; 37(1):251-7. PubMed ID: 26718491 [TBL] [Abstract][Full Text] [Related]